{"id":11625,"date":"2003-09-01T06:20:09","date_gmt":"2003-09-01T06:20:09","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=11625"},"modified":"2013-07-16T10:21:34","modified_gmt":"2013-07-16T10:21:34","slug":"2nd-ias-conference-on-hiv-pathogenesis-and-treatment","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/11625","title":{"rendered":"2nd IAS Conference on HIV Pathogenesis and Treatment, 13-16 July 2003, Paris"},"content":{"rendered":"<h2>Introduction<\/h2>\n<p><strong>This biannual conference alternates with the the International AIDS (World AIDS) conferences. <\/strong><\/p>\n<p>Location is also planned to alternate between a developed country and one where access to treatment is still not widely available &#8211; the first meeting was held in Buenos Aires in 2001 \u2013 in order to maintain a balance between new science and the importance of access issues.<\/p>\n<p>The second meeting \u2013 this year in Paris \u2013 attracted 6,000 delegates from 120 countries. One thousand eight hundred abstracts were received, 180 of which were selected for oral presentations and more than 900 for poster presentations. None of them however were available online as we went to press &#8211; although webcasts and other resources for all conference plenaries and selected other sessions are provided by the Kaiser Family Foundation online; they do not include the facility to see the slides being referred to in the lectures:<\/p>\n<p><a href=\"http:\/\/www.kaisernetwork.org\"> http:\/\/www.kaisernetwork.org<\/a><\/p>\n<p>Webcasts include:<\/p>\n<p><strong>Main plenaries<\/strong><\/p>\n<ul>\n<li>Challenges and lessons learned in implementing antiretroviral therapy in the developing world<\/li>\n<li>Host\/virus mechanisms in the molecular pathogenesis of HIV<\/li>\n<li>New antiretroviral drugs and therapeutic strategies<\/li>\n<li>HIV vaccine research: the state of the science<\/li>\n<li>HIV entry: insights into viral tropism, pathogenesis, and antiviral therapy<\/li>\n<li>Mechanisms and management of metabolic complications associated with highly active antiretroviral therapy<\/li>\n<\/ul>\n<p><strong>Forum Lectures<\/strong><\/p>\n<ul>\n<li>HIV drug resistance<\/li>\n<li>The scaling-up of antiretroviral therapy in developing countries<\/li>\n<li>Mother-to-child HIV transmission<\/li>\n<\/ul>\n<p><strong>Keynote Lectures<\/strong><\/p>\n<ul>\n<li>20 Years of HIV Science<\/li>\n<li>From Science to Action: Challenges in Managing AIDS<\/li>\n<\/ul>\n<p>Reports in this issue of HTB are:<\/p>\n<ul>\n<li><a title=\"Permanent link to Nevirapine and MTCT: the single-dose backlash\" href=\"https:\/\/i-base.info\/htb\/11623\" rel=\"bookmark\">Nevirapine and MTCT: the single-dose backlash<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Triple nucleoside combinations fail patients again\" href=\"https:\/\/i-base.info\/htb\/11621\" rel=\"bookmark\">Triple nucleoside combinations fail patients again<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Nucleoside-sparing regimens\" href=\"https:\/\/i-base.info\/htb\/11619\" rel=\"bookmark\">Nucleoside-sparing regimens<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Dual boosted PIs in salvage therapy\" href=\"https:\/\/i-base.info\/htb\/11617\" rel=\"bookmark\">Dual boosted PIs in salvage therapy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to BMS reports on atazanavir efficacy and safety in treatment experienced patients\" href=\"https:\/\/i-base.info\/htb\/11613\" rel=\"bookmark\">BMS reports on atazanavir efficacy and safety in treatment experienced patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Unsupervised treatment interruptions are associated with increased risk of AIDS or death\" href=\"https:\/\/i-base.info\/htb\/11610\" rel=\"bookmark\">Unsupervised treatment interruptions are associated with increased risk of AIDS or death<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Uridine as a potential treatment for NRTI related mitochondrial toxicity\" href=\"https:\/\/i-base.info\/htb\/7000\" rel=\"bookmark\">Uridine as a potential treatment for NRTI related mitochondrial toxicity<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Long term exposure to nucleoside analogues and peripheral nerve function\" href=\"https:\/\/i-base.info\/htb\/11606\" rel=\"bookmark\">Long term exposure to nucleoside analogues and peripheral nerve function<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Step-wise intervention eases diarrhoea linked to PI nelfinavir (Viracept) therapy\" href=\"https:\/\/i-base.info\/htb\/11604\" rel=\"bookmark\">Step-wise intervention eases diarrhoea linked to PI nelfinavir (Viracept) therapy<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to First results from ESPRIT study: CD4 response to IL-2 is associated with higher nadir and baseline CD4 and younger age\" href=\"https:\/\/i-base.info\/htb\/11602\" rel=\"bookmark\">First results from ESPRIT study: CD4 response to IL-2 is associated with higher nadir and baseline CD4 and younger age<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lessons learned from early HAART in acute HIV infection\" href=\"https:\/\/i-base.info\/htb\/11600\" rel=\"bookmark\">Lessons learned from early HAART in acute HIV infection<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to CD4 cell reconstitution is significantly slower in older patients\" href=\"https:\/\/i-base.info\/htb\/11598\" rel=\"bookmark\">CD4 cell reconstitution is significantly slower in older patients<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Pharmacology studies at the 2nd IAS conference\" href=\"https:\/\/i-base.info\/htb\/11595\" rel=\"bookmark\">Pharmacology studies at the 2nd IAS conference<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Studies highlight problems of rectal disease in HIV-positive patients\" href=\"https:\/\/i-base.info\/htb\/11593\" rel=\"bookmark\">Studies highlight problems of rectal disease in HIV-positive patients<\/a><\/li>\n<\/ul>\n<p>Further reports will also be included in the next issue.<\/p>\n<p>All references are from the programme and abstracts of The 2nd IAS conference on HIV pathogenesis and treatment, Paris, France 13-16 July 2003 unless otherwise stated.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction This biannual conference alternates with the the International AIDS (World AIDS) conferences. Location is also planned to alternate between a developed country and one where access to treatment is still not widely available &#8211; the first meeting was held &hellip;<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,90],"class_list":["post-11625","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-ias-2nd-2003"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11625","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=11625"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/11625\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=11625"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=11625"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=11625"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}